The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

作者: F. Kratz , M. Hartmann , B. Keppler , L. Messori

DOI: 10.1016/S0021-9258(17)41984-3

关键词: TransferrinPlasma protein bindingMetalBinding siteBlood proteinsMedicinal chemistryStereochemistryAdductChemistryRutheniumNAMI-A

摘要: The interaction of two ruthenium(III) complexes exhibiting high anticancer activity, namely trans-indazolium(bisindazole)tetrachlororuthenate(III) (ru-ind) and trans-imidazolium(bisimidazole)tetrachlororuthenate(III) (ru-im), with human serum apotransferrin has been investigated through spectroscopic chromatographic techniques the ultimate goal preparing adducts good selectivity for cancer cells. Whereas binding ru-im to takes several hours, ru-ind, less toxic complex, gives rise a well defined 2:1 complex within few minutes. We have ascertained that ru-ind occurs around iron sites; does not occur in absence bicarbonate, this anion dictates kinetic mechanistic characteristics protein ru-ind. do behave as iron(III) complexes, e.g. Fe(EDTA) or Fe(nitrilotriacetate), which lose their respective ligands when apotransferrin, but N-heterocycles remain attached metal protein-bound species. Reversion is obtained by acidification presence chelators such citrate ATP. In comparison cisplatin its deactivation proteins, our results indicate other could use transferrin drug delivery system. Furthermore, rapid seems be related lower toxicity while still antitumor activity.

参考文章(13)
GW Bates, MR Schlabach, The nonspecific binding of Fe3+ to transferrin in the absence of synergistic anions. Journal of Biological Chemistry. ,vol. 250, pp. 2177- 2181 ,(1975) , 10.1016/S0021-9258(19)41698-0
H H Wellhöner, D M Neville, K Srinivasachar, G Erdmann, Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid-labile transferrin conjugate. Journal of Biological Chemistry. ,vol. 266, pp. 4309- 4314 ,(1991) , 10.1016/S0021-9258(20)64323-X
Seiki Minamide, Sakiko Nagamine, Toshiyuki Seki, Michiyo Ono, Minoru Iwabuchi, Kiyohiro Nishikawa, Katsutoshi Takahashi, Hiroo Horinishi, Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. Japanese Journal of Cancer Research. ,vol. 76, pp. 68- 74 ,(1985) , 10.20772/CANCERSCI1985.76.1_68
Bryan F. Andersen, Heather M. Baker, Gillian E. Morris, Sylvia V. Rumball, Edward N. Baker, Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature. ,vol. 344, pp. 784- 787 ,(1990) , 10.1038/344784A0
Salvatore V. Pizzo, Mark W. Swaim, Paul A. Roche, Steven L. Gonias, Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. Journal of Inorganic Biochemistry. ,vol. 33, pp. 67- 76 ,(1988) , 10.1016/0162-0134(88)80035-7
Felix Kratz, Luigi Messori, Spectral characterization of ruthenium(III) transferrin Journal of Inorganic Biochemistry. ,vol. 49, pp. 79- 82 ,(1993) , 10.1016/0162-0134(93)85017-3
Robert R. Crichton, Roberta J. Ward, Iron-metabolism : new perspectives in view Biochemistry. ,vol. 31, pp. 11255- 11264 ,(1992) , 10.1021/BI00161A001
P. T. Manoharan, P. K. Mehrotra, M. M. Taquikhan, R. K. Andal, Optical and magnetic properties and geometry of some d5 ruthenium complexes Inorganic Chemistry. ,vol. 12, pp. 2753- 2757 ,(1973) , 10.1021/IC50130A003
Edward N. Baker, Peter F. Lindley, New perspectives on the structure and function of transferrins. Journal of Inorganic Biochemistry. ,vol. 47, pp. 147- 160 ,(1992) , 10.1016/0162-0134(92)84061-Q